What is PacGenomics?
PacGenomics operates as an advanced clinical laboratory, specializing in cutting-edge molecular diagnostics. The company offers a comprehensive suite of services, including infectious disease testing, clinical toxicology, sequencing services, DNA identity testing, and preimplantation genetic testing. Leveraging sophisticated technologies such as Next-Generation Sequencing and Liquid Chromatography-Mass Spectrometry, PacGenomics delivers precise and thorough analysis to healthcare providers and patients. Their commitment to high standards of quality control and data integrity is maintained by a dedicated team of skilled laboratory professionals, supporting diverse needs from paternity verification to reproductive genetic testing and empowering precision healthcare.
How much funding has PacGenomics raised?
PacGenomics has raised a total of $4.7M across 3 funding rounds:
Private Equity
$1.5M
Private Equity
$3M
Debt
$150K
Private Equity (2013): $1.5M, investors not publicly disclosed
Private Equity (2014): $3M, investors not publicly disclosed
Debt (2020): $150K supported by PPP
Key Investors in PacGenomics
PPP
Public-Private Partnership
What's next for PacGenomics?
The recent major strategic investment signals a pivotal phase for PacGenomics, likely enabling expansion of its diagnostic service offerings and enhancement of its technological infrastructure. This capital infusion is expected to accelerate the company's market penetration and solidify its role in advancing precision medicine. Future developments may include the integration of new diagnostic platforms and the broadening of its service reach to address evolving healthcare demands.
See full PacGenomics company page
